Evidence map›Paper›PMID 35869978›Full record

ArticleJournal of molecular cell biology2022

AIM-CICs: an automatic identification method for cell-in-cell structures based on convolutional neural network.

Meng Tang, Yan Su, Wei Zhao, Zubiao Niu, Banzhan Ruan, Qinqin Li, You Zheng, Chenxi Wang, Bo Zhang, Fuxiang Zhou and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of molecular cell biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Meng TangBeijing Shijitan Hospital of Capital Medical University, Beijing 100038, China.
Yan SuLaboratory of Cell Engineering, Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Science, 2021RU008, Beijing 100071, China.
Wei ZhaoSchool of Mathematical Sciences, Peking University, Beijing 100871, China.
Zubiao NiuLaboratory of Cell Engineering, Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Science, 2021RU008, Beijing 100071, China.
Banzhan RuanLaboratory of Cell Engineering, Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Science, 2021RU008, Beijing 100071, China.
Qinqin LiBeijing Shijitan Hospital of Capital Medical University, Beijing 100038, China.
You ZhengLaboratory of Cell Engineering, Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Science, 2021RU008, Beijing 100071, China.
Chenxi WangLaboratory of Cell Engineering, Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Science, 2021RU008, Beijing 100071, China.
Bo ZhangBeijing Shijitan Hospital of Capital Medical University, Beijing 100038, China.
Fuxiang ZhouDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Clinical Cancer Study Center, Zhongnan Hospital, Wuhan University, Wuhan 430071, China.
Xiaoning WangNational Clinic Center of Geriatric & State Key Laboratory of Kidney, Chinese PLA General Hospital, Beijing 100853, China.
Hongyan HuangBeijing Shijitan Hospital of Capital Medical University, Beijing 100038, China.
Hanping ShiBeijing Shijitan Hospital of Capital Medical University, Beijing 100038, China.
Qiang SunLaboratory of Cell Engineering, Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Science, 2021RU008, Beijing 100071, China.ORCID 0000-0002-5342-0637
Chinese Academy of Medical Sciences & Peking Union Medical College · CNCapital Medical University · CNChinese PLA General Hospital · CNPeking University · CNWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Edited by Luonan Chen Whereas biochemical markers are available for most types of cell death, current studies on non-autonomous cell death by entosis rely strictly on the identification of cell-in-cell structures (CICs), a unique morphological readout that can only be quantified manually at present. Moreover, the manual CIC quantification is generally over-simplified as CIC counts, which represents a major hurdle against profound mechanistic investigations. In this study, we take advantage of artificial intelligence technology to develop an automatic identification method for CICs (AIM-CICs), which performs comprehensive CIC analysis in an automated and efficient way. The AIM-CICs, developed on the algorithm of convolutional neural network, can not only differentiate between CICs and non-CICs (the area under the receiver operating characteristic curve (AUC) > 0.99), but also accurately categorize CICs into five subclasses based on CIC stages and cell number involved (AUC > 0.97 for all subclasses). The application of AIM-CICs would systemically fuel research on CIC-mediated cell death, such as high-throughput screening.

Indexed as

Artificial IntelligenceNeural Networks, ComputerBiomarkersBiomarkersAIM-CICsartificial intelligencecell deathcell-in-cell structureconvolutional neural networkentosis

Identifiers

PMID35869978
PMCPMC9701057
OpenAlexW4286750394

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.